Molecular
diagnostics market is expected to grow over the forecast period owing to
the evolution of CLIA waived tests related to the point of care (POC) for
molecular advanced diagnostics, cancer diagnostic and detection technologies
Other drivers of this market are growing prevalence of cancer, blood screening,
genetic disorders, and improper lifestyle habit such as alcohol, tobacco
consumption, smoking and increasing geriatric population. CLIA tests are
performed on humans for health assessments, treatment of impairment or disease,
prevention, diagnosis. So to meet complexity, error and risk requirements CLIA
certificate of waiver are issued. The molecular diagnostics are used for early
detection of genetic disorders, infectious diseases, and cancer. For detection
of genetic disorders, various applications and technologies are used for its
detection in pre-natal stages. In the upcoming years, molecular diagnostics
market demand is expected show high growth. The market is equipped with
pre-natal stage detection technology
Browse
Detail Report with TOC @
Product
Insights
Molecular diagnostics market is
segmented on the basis of product types into reagents and instruments.
Globally, reagents held the largest market share in 2013. The reason for its
dominance is that it has high usage rate in molecular test and also more
preference is given to it over counter tests. Molecular diagnostic test are now
being used at non-medical facilities such as schools, college, and homes. Due
to increasing demand for advanced cancer diagnostic tests and genetic test,
this market will grow at a CAGR of 10% over the forecast period. Apart from
regents, globally instrument market is also growing at a fare pace and
contributing nearly 38.4% in total market share, as these instrument products
are quite costly, as compared to reagents market.
Technology
Insights
Molecular diagnostics market is segmented
on the basis of technology intoin situ hybridization, PCR, mass spectrometry,
chips & microarrays and sequencing. Among these PCR held the largest market
share in 2013. PCR process is used in detection of diseases such as, viral
infections, lymphoma and leukaemia. The importance of this technology is that
it targets the DNA sequences and finds its amplification. This technology is
used by medical practitioners and researchers, in finding out the DNA sequence,
so to find out the factors or reasons for cancer and accordingly develop
treatment procedures for it. Increasing prevalence of cancerhas triggered the
cancer market a lot, so it can be said that it is one the key driver for PCR
technology market.
Application
Insights
Molecular diagnostics market is
segmented on the basis of application into pharmacogenomics, oncology, genetic
testing, infectious disease, cardiovascular disease, and neurological disease.
Among these, oncology application held the largest market share in 2013, as 34%
of revenue is generated by this segment alone. Reason for its dominance is due
to presence of high cancer patient cases and evolution of advanced tests such
as companion diagnostics. Companion diagnostics are the personalized medicine
and also include identification of biomarker response for the selected
patients. Pharmacogenomics application is the fastest growing application.
Pharmacogenomics is the study of genetic mapping according to the patient’s
response towards a particular drug and therapy.
Regional
Insights
Geographically, the Molecular
diagnostics market is studied with respect to North America, Europe, Asia
Pacific and RoW. North America is dominating the whole market as it has strong
healthcare infrastructure, patient awareness, various government programmes,
and strong R&D. Asia Pacific is expected to show fruitful CAGR over the
forecast period owing to the rapidly developing healthcare infrastructure
areincreasing patient awareness, and various government initiatives.
Request
a Sample copy of This Report @ http://www.hexaresearch.com/sample/38
Competitive Insights
The major market players in, the
molecular diagnostics market are, Roche Diagnostics, Gen-Probe, Hologic,
bioMerieux, Novartis, Abbott Laboratories, Siemens Healthcare, Qiagen, Hologic,
Becton Dickinson and Company and Cepheid.
Table of Contents
Chapter 1. Executive Summary
1.1. Molecular Diagnostics - Industry Summary and Critical
Success Factors (CSFs)
Chapter 2. Molecular
Diagnostics Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Molecular Diagnostics Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Molecular Diagnostics - Company Market Share Analysis
2.7. Molecular Diagnostics Market PESTEL Analysis, 2012
Browse
Full Report @
About
Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact
Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - http://www.hexaresearch.com/
